EACH ISSUE CONTAINS

Paper alerts
Expert commentary on a selection of recently published papers is provided.

Patent alerts
Brief commentaries on the scientific and/or commercial significance of new patents selected and written by experts within their respective fields. These are presented beside the patent abstract, published by Thomson Reuters.

Editorial overview
Short overviews in which an area of interest to the pharmaceutical industry is critically reviewed in the context of recent developments.

Reviews
Concise reviews in which authors present recent developments in their subject, emphasizing the aspects that, in their opinion, are most important. In addition, they provide short annotations to the cited papers that they consider to be the most interesting from all those published in their topic. Papers chosen by an author as being 'of special interest' or 'of outstanding interest' are clearly identified in the reference list at the end of each review. The reviews focus predominantly on investigational drugs, or the therapeutic/commercial applications of new discoveries.

Drug profiles
Expert commentary on the scientific and commercial potential of selected drugs in clinical trials are provided in each issue, in the form of drug profiles. A drug profile is a review of the available literature (scientific and commercial), including the authors opinion of the drug’s therapeutic and commercial potential. Further information on these drugs appears in Thomson Reuters' Investigational Drugs database (IDdb) and Thomson Pharma platform.

Annual indexes
In the last issue of each volume, cumulative indexes of contents, subjects and authors are provided.

Current Opinion in Investigational Drugs contains contributions from internationally recognized leaders in pharmaceutical R&D. All contributions are invited and peer-reviewed by an Editorial Board comprising of distinguished members of the scientific community.

EDITOR IN CHIEF

Michael Williams (USA)

CO-EDITORS

Stanley Crooke (USA)
Annette Doherty (UK)
William Hagmann (USA)
John Kemp (Germany)
Jacob J Plattner (USA)

PATENT EDITOR

Hermann AM Mucke (Austria)

SECTION EDITORS

The Section Editors are internationally recognized leaders of their field. They are responsible for the sections of the journal, and divide each section into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasized.

Anti-infectives Robin Cooper (USA), Simon Croft (UK), Christian Hubschwerlen (Switzerland), Jeffrey H Toney (USA), Alan Johnson (UK), Barney Koszalka (USA), Nicholas Meanwell (USA), Rino Rappuoli (Italy)

Anti-inflammatory, Immunologicals and Biologicals Bruce Cronstein (USA), Cynthia Darlington (New Zealand), David Howat (France)

Cardiovascular and renal Frank Barone (USA), Tom Colatsky (USA), De-Zai Dai (China), Delvin Knight (USA), Brian Krause (USA), Keith E Suckling (UK), J Ruth Wu-Wong (USA)

Central and Peripheral Nervous System Mike Briley (France), Robert Davis (USA), Steve England (UK), Peter Goadsby (UK), Robert McArthur (Switzerland), Clifford Woolf (USA), Mike Wyllie (UK), Stevin Zorn (USA)

Endocrine and Metabolics Franklyn Bolander (USA), Nigel Levens (USA), Michael Murphy (UK), Terry Opgenorth (USA)

Oncological Shripad Bhagwat (USA), David Gewirtz (USA), Michael Lotze (USA), Alain Rolland (USA), Edward Sausville (USA), Ian Stratford (UK), Mario Sznol (USA), Paul Workman (UK)